Bates SE - Search Results

1

A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.

Leuva H, Sigel K, Zhou M, Wilkerson J, Aggen DH, Park YA, Anderson CB, Hsu TM, Langhoff E, McWilliams G, Drake CG, Simon R, Bates SE, Fojo T. Leuva H, et al. Among authors: bates se. Semin Oncol. 2019 Aug-Oct;46(4-5):351-361. doi: 10.1053/j.seminoncol.2019.11.004. Epub 2019 Nov 16. Semin Oncol. 2019. PMID: 31757478 Review.

2

Resistance to paclitaxel mediated by P-glycoprotein can be modulated by changes in the schedule of administration.

Zhan Z, Scala S, Monks A, Hose C, Bates S, Fojo T. Zhan Z, et al. Cancer Chemother Pharmacol. 1997;40(3):245-50. doi: 10.1007/s002800050654. Cancer Chemother Pharmacol. 1997. PMID: 9219509

3

The role of MDR-1 in refractory lymphoma.

Sandor V, Wilson W, Fojo T, Bates SE. Sandor V, et al. Among authors: bates se. Leuk Lymphoma. 1997 Dec;28(1-2):23-31. doi: 10.3109/10428199709058327. Leuk Lymphoma. 1997. PMID: 9498700 Review.

4

Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.

Chen CC, Meadows B, Regis J, Kalafsky G, Fojo T, Carrasquillo JA, Bates SE. Chen CC, et al. Among authors: bates se. Clin Cancer Res. 1997 Apr;3(4):545-52. Clin Cancer Res. 1997. PMID: 9815718

5

Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833.

Chico I, Kang MH, Bergan R, Abraham J, Bakke S, Meadows B, Rutt A, Robey R, Choyke P, Merino M, Goldspiel B, Smith T, Steinberg S, Figg WD, Fojo T, Bates S. Chico I, et al. J Clin Oncol. 2001 Feb 1;19(3):832-42. doi: 10.1200/JCO.2001.19.3.832. J Clin Oncol. 2001. PMID: 11157037 Clinical Trial.

6

Multidrug resistance in cancer: role of ATP-dependent transporters.

Gottesman MM, Fojo T, Bates SE. Gottesman MM, et al. Among authors: bates se. Nat Rev Cancer. 2002 Jan;2(1):48-58. doi: 10.1038/nrc706. Nat Rev Cancer. 2002. PMID: 11902585 Review.

7

The role of ABC transporters in clinical practice.

Leonard GD, Fojo T, Bates SE. Leonard GD, et al. Among authors: bates se. Oncologist. 2003;8(5):411-24. doi: 10.1634/theoncologist.8-5-411. Oncologist. 2003. PMID: 14530494 Free article. Review.

8

A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins.

Stein WD, Litman T, Fojo T, Bates SE. Stein WD, et al. Among authors: bates se. Cancer Res. 2004 Apr 15;64(8):2805-16. doi: 10.1158/0008-5472.can-03-3383. Cancer Res. 2004. PMID: 15087397

9

Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack.

Stein WD, Bates SE, Fojo T. Stein WD, et al. Among authors: bates se. Curr Drug Targets. 2004 May;5(4):333-46. doi: 10.2174/1389450043345489. Curr Drug Targets. 2004. PMID: 15134216 Review.

10

Differential expression of cell adhesion genes: implications for drug resistance.

Stein WD, Litman T, Fojo T, Bates SE. Stein WD, et al. Among authors: bates se. Int J Cancer. 2005 Mar 1;113(6):861-5. doi: 10.1002/ijc.20671. Int J Cancer. 2005. PMID: 15514970 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page